CLINICAL TRIALS PROFILE FOR TRIDIL
✉ Email this page to a colleague
All Clinical Trials for TRIDIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02343276 ↗ | Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs | Completed | Instituto de Cardiologia de Santa Catarina | Phase 3 | 2015-02-01 | Single-center study, randomized, double-blind, placebo controlled, with patients undergoing diagnostic or therapeutic catheterization via the transradial approach. Patients will be randomized into two groups: one group will receive the vasodilator nitroglycerin during the procedure (intervention group), and a second group will receive saline 0.9% in the same volume and time during the procedure (control group). Will be evaluated: incidence of spasms of the radial artery, ability to perform the procedure without the need to change the access site, pain presented by the patient, time and total radiation of the procedure. |
| NCT03059316 ↗ | Effect of Hypotensive Anesthesia on the Perfusion Index | Completed | Cairo University | Early Phase 1 | 2016-06-10 | Controlled hypotension has been used as a mean of reducing intraoperative blood loss and better visualization of the surgical field in nasal surgeries. Perfusion index has been considered a useful tool for monitoring changes in peripheral perfusion using Masimo set and serum lactate for central perfusion. Many medications were used to induce hypotension. In this study we will compare the effects of tridil and labetalol on the perfusion. |
| NCT03158532 ↗ | Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin | Recruiting | Instituto de Cardiologia de Santa Catarina | Phase 3 | 2017-07-06 | The radial approach for a coronary angiography has became popular in several centers because of its simplicity and fewer complications. The radial artery occlusion (RAO) is the main inconvenient and impose a limitation of future use of the radial artery as an access site for catheterization in the future. Several strategies have been used to decrease the incidence of RAO (heparin, patent hemostasis, etc). Nitrates in intra-arterial have been widely studied in prevention of this spasm. Current data show that nitroglycerin intra-arterial at the end of the procedure reduce the incidence of RAO. The hypothesis that use of nitroglycerin at the start of catheterization would have the same effect was not tested. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRIDIL
Condition Name
Clinical Trial Locations for TRIDIL
Clinical Trial Progress for TRIDIL
Clinical Trial Phase
Clinical Trial Sponsors for TRIDIL
Sponsor Name
